Balázs Halmos
0000-0001-7548-8360
Publication & Citation Trends
Publications
0 total
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.
Cited by 1
Semantic Scholar
289 COPERNICUS: A Multinational Pragmatic Phase 2 Trial of Subcutaneous (SC) Amivantamab (Ami) in Common EGFR-Mutated (cEGFRm) NSCLC
Cited by 0
Semantic Scholar
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Cited by 1
Semantic Scholar
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC
Cited by 0
Semantic Scholar
ATM functions as a rheostat of metabolic stress in small-cell lung cancer
Cited by 0
Semantic Scholar
Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC
Cited by 0
Semantic Scholar
Abstract 2434: Prognostic and predictive effects of TP53 co-mutations and RET fusion partners in RET -rearranged advanced NSCLC
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(358)
Cancer Immunotherapy and Biomarkers
(98)
Lung Cancer Research Studies
(75)
Lung Cancer Diagnosis and Treatment
(73)
Colorectal Cancer Treatments and Studies
(68)
Affiliations
Semmelweis University
Brigham and Women's Hospital
Roswell Park Comprehensive Cancer Center
Albert Einstein College of Medicine
Beth Israel Deaconess Medical Center